Access a Proven Engine for Peptide and Macrocyclic Innovation

Securing a competitive edge in today's market requires more than just a lead; it requires a partner with a proven ability to translate innovative science into clinical success.

IRBM is a fully integrated drug discovery organization with deep expertise in peptide and macrocyclic modalities. Our ~200-scientist, single-site platform spans the entire value chain from Target ID to Pre-IND, combining medicinal chemistry with cutting-edge capabilities in CADD, NMR, ADME/DMPK, Phage Display, and MedChem — all under one roof, enabling seamless project progression and faster, data-driven decision-making at every stage.

Value for your portfolio:

Access to a truly integrated environment designed to accelerate innovation. Whether your focus is macrocyclic peptides, peptide conjugates, or radiotheragnostic peptides, IRBM provides end-to-end support, from early discovery through preclinical development. What truly sets us apart? The ability to explore new chemical spaces and address challenging targets, with a compelling track record: IRBM scientists have actively contributed to 100+ patents — underscoring our role not simply as executors, but also inventors who bring genuine scientific creativity and co-ownership to every program we engage with.

Explore Our Partnership Capabilities & Modality Expertise

To schedule a substantive conversation, please request an appointment through the TIDES Event App or reply directly to this email to find a time that works for you.

Featured Video

▶ Watch: From Concept to Candidate: Your Peptide Journey with IRBM